Yahoo
NYSE USD

GMR Solutions Inc. (GMRS)

12.44 -0.07 (-0.56%)
At close: November 6 at 4:00:02 PM EST
12.44 0.00 (0.00%)
After hours: November 6 at 4:01:19 PM EST
GMRS Q3 2026 earnings call
November 10, 2026 at 8 AM EST
Chart Range Bar
Loading chart for GMRS
  • Previous Close 12.51
  • Open 12.29
  • Bid 10.29 x 20000
  • Ask 14.00 x 10000
  • Day's Range 12.00 - 12.64
  • 52 Week Range 9.00 - 15.98
  • Volume 810,034
  • Avg. Volume 931,623
  • Market Cap (intraday) 672.03M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -2.03
  • Earnings Date Nov 9, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 18.62
  • Zacks Rating Neutral

GMR Solutions Inc. operates as a provider of emergency medical services (EMS), essential alternate-site, out-of-hospital care, and mobile clinical practice groups in United States. It offers emergent medical services; non-emergent services; and other solutions, such as membership programs, standby and special events, national ambulance contract with the federal emergency management agency, and other state agency and health system contracts to coordinate EMS responses. It serves health systems, large regional systems, and smaller independent hospitals, local communities, health systems, payors, public health and local, state, and federal agencies. The company was incorporated in 2015 and is headquartered in Lewisville, Texas.

globalmedicalresponse.com

34,000

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

GMRS
7.85%
S&P 500 (^GSPC)
7.76%

1-Year Return

GMRS
7.85%
S&P 500 (^GSPC)
9.77%

3-Year Return

GMRS
7.85%
S&P 500 (^GSPC)
68.96%

5-Year Return

GMRS
7.85%
S&P 500 (^GSPC)
57.04%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Analyst Insights

View More

Analyst Price Targets

14.00
18.62 Average
12.44 Current
30.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 9/11/2026
Analyst JP Morgan
Rating Action Maintains
Rating Overweight
Price Action Raises
Price Target 15 -> 16

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.81%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    5.88B

  • Net Income Avi to Common (ttm)

    -75.65M

  • Diluted EPS (ttm)

    -2.03

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    420M

  • Total Debt/Equity (mrq)

    602.46%

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: